Deep ultraviolet nonlinear microscopy in thick tissue
Project Number5R21EB005736-02
Contact PI/Project LeaderMERTZ, JEROME C
Awardee OrganizationBOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
Description
Abstract Text
DESCRIPTION (provided by applicant): The aim of this project is to extend optical microscopy into the deep ultraviolet (DUV) wavelength range, and characterize DUV endogenous signals obtained from unlabeled biological tissue. We define DUV wavelengths as ranging from 230 nm to 350nm. This range is rarely investigated in microscopy because DUV light does not transmit through ordinary glass, and hence cannot be observed with standard microscope optics. Our basic hypothesis is that DUV optical microscopy can reveal clinically relevant information on cells and tissue structures that is normally unobservable.
Our proposed technique will be based on the use of a nonlinear microscope to produce DUV three-photon excited autofluorescence (3PEF) and third-harmonic generation (3HG). These signals are intrinsic and do not require sample labeling. We will exploit the advantages of nonlinear microscopy over standard (linear) microscopy for accessing the DUV spectral window, and will develop a novel light collection technique specifically designed for detection in the backward direction, thereby allowing DUV imaging in thick tissues. In addition, we will integrate our nonlinear microscope with a custom designed spectrograph to allow both high-resolution imaging and spectral analysis. As far as we know, DUV imaging (as defined here) in a thick tissue with a nonlinear microscope has never been performed before.
Our goal in this project is to demonstrate sub-cellular resolution DUV imaging in unlabelled brain and cancer tissue, and to demonstrate the unambiguous identification of molecular species in the DUV spectral range using recently developed techniques of spectral decomposition. Ultimately, we hope to confirm our hypothesis that intrinsic optical signals in the DUV spectral window, which has largely been overlooked so far, can provide useful and clinically relevant information.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
049435266
UEI
THL6A6JLE1S7
Project Start Date
06-September-2005
Project End Date
31-July-2007
Budget Start Date
01-August-2006
Budget End Date
31-July-2007
Project Funding Information for 2006
Total Funding
$157,705
Direct Costs
$97,650
Indirect Costs
$60,055
Year
Funding IC
FY Total Cost by IC
2006
National Institute of Biomedical Imaging and Bioengineering
$157,705
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21EB005736-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21EB005736-02
Patents
No Patents information available for 5R21EB005736-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21EB005736-02
Clinical Studies
No Clinical Studies information available for 5R21EB005736-02
News and More
Related News Releases
No news release information available for 5R21EB005736-02
History
No Historical information available for 5R21EB005736-02
Similar Projects
No Similar Projects information available for 5R21EB005736-02